The global snake antivenom market, valued at USD 332.73 million in 2023, is poised to expand at a compound annual growth rate (CAGR) of 7.5% through the forecast period, reflecting increasing demand for life-saving therapies and heightened awareness of snakebite envenoming, particularly in tropical and subtropical regions. Market Overview Snakebite envenoming remains a major...